Kimberly H. Sheehy
Known title: DirectorCIK: 0001567047
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
CVBF Featured in Two Yahoo Bank Articles. CVBF was named in two recent Yahoo pieces. One highlighted it as a stock under $50 that raises concerns, while the other noted it as a regional bank that could benefit from higher rates. These pieces suggest traders are watching the bank’s valuation and rate sensitivity.
Transaction History
| EVLV | ▲ Buy | Option Exercise | 27,050 | $0 | 6/17/2026 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 54,195 | $0 | 5/31/2025 | View on chart |
| CVBF | ▲ Buy | Grant | 4,462 | $0 | 5/21/2025 | View on chart |
| CVBF | ▼ Sell | Open Market | 2,961 | $51K | 7/2/2024 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 25,846 | $0 | 5/30/2024 | View on chart |
| CVBF | ▲ Buy | Grant | 4,899 | $0 | 5/15/2024 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 48,494 | $0 | 5/26/2023 | View on chart |
| CVBF | ▲ Buy | Grant | 8,257 | $0 | 5/17/2023 | View on chart |
| CVBF | ▲ Buy | Grant | 2,961 | $0 | 6/15/2022 | View on chart |
| EVLV | ▲ Buy | Option Exercise | 14,500 | $0 | 5/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
EVLV: Analysts Highlight Overlooked Growth Potential
Recent commentary suggests Evolv Technologies may be undervalued, with analysts pointing to growth factors that the market is currently ignoring. This perspective contrasts with the stock's recent weakness, as it trades near its 52-week low and shows high beta volatility. The average analyst target remains significantly higher than the current price, indicating a potential gap between market sentiment and fundamental expectations.
EVLV: Analysts Highlight Overlooked Growth Potential. Recent commentary suggests Evolv Technologies may be undervalued, with analysts pointing to growth factors that the market is currently ignoring. This perspective contrasts with the stock's recent weakness, as it trades near its 52-week low and shows high beta volatility. The average analyst target remains significantly higher than the current price, indicating a potential gap between market sentiment and fundamental expectations.